Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Vibrio cholerae: lessons for mucosal vaccine design.

Bishop AL, Camilli A.

Expert Rev Vaccines. 2011 Jan;10(1):79-94. doi: 10.1586/erv.10.150. Review.

2.

Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.

Shamsuzzaman S, Ahmed T, Mannoor K, Begum YA, Bardhan PK, Sack RB, Sack DA, Svennerholm AM, Holmgren J, Qadri F.

Vaccine. 2009 Feb 25;27(9):1386-92. doi: 10.1016/j.vaccine.2008.12.041. Epub 2009 Jan 13.

PMID:
19146897
3.

Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.

Saha A, Chowdhury MI, Khanam F, Bhuiyan MS, Chowdhury F, Khan AI, Khan IA, Clemens J, Ali M, Cravioto A, Qadri F.

Vaccine. 2011 Oct 26;29(46):8285-92. doi: 10.1016/j.vaccine.2011.08.108. Epub 2011 Sep 9.

PMID:
21907255
4.

Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.

Anh DD, Canh DG, Lopez AL, Thiem VD, Long PT, Son NH, Deen J, von Seidlein L, Carbis R, Han SH, Shin SH, Attridge S, Holmgren J, Clemens J.

Vaccine. 2007 Jan 22;25(6):1149-55. Epub 2006 Sep 29.

PMID:
17055622
5.

Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.

Charles RC, Hilaire IJ, Mayo-Smith LM, Teng JE, Jerome JG, Franke MF, Saha A, Yu Y, Kováč P, Calderwood SB, Ryan ET, LaRocque RC, Almazor CP, Qadri F, Ivers LC, Harris JB.

PLoS Negl Trop Dis. 2014 May 1;8(5):e2828. doi: 10.1371/journal.pntd.0002828. eCollection 2014 May.

6.

Questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003.

Kabir S.

Vaccine. 2007 Feb 9;25(8):1353-4. Epub 2006 Oct 4. No abstract available.

PMID:
17049687
7.

A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in Ethiopia.

Desai SN, Akalu Z, Teshome S, Teferi M, Yamuah L, Kim DR, Yang JS, Hussein J, Park JY, Jang MS, Mesganaw C, Taye H, Beyene D, Bedru A, Singh AP, Wierzba TF, Aseffa A.

Am J Trop Med Hyg. 2015 Sep;93(3):527-33. doi: 10.4269/ajtmh.14-0683. Epub 2015 Jun 15.

8.

Cholera vaccine: new preventive tool for endemic countries.

Verma R, Khanna P, Chawla S.

Hum Vaccin Immunother. 2012 May;8(5):682-4. doi: 10.4161/hv.19083. Epub 2012 May 1. Review.

PMID:
22634452
9.

Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.

Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Han SH, Attridge S, Donner A, Ganguly NK, Bhattacharya SK, Nair GB, Clemens JD, Lopez AL.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1289. doi: 10.1371/journal.pntd.0001289. Epub 2011 Oct 18.

10.

Immune responses to cholera in children.

Leung DT, Chowdhury F, Calderwood SB, Qadri F, Ryan ET.

Expert Rev Anti Infect Ther. 2012 Apr;10(4):435-44. doi: 10.1586/eri.12.23. Review.

11.

5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.

Bhattacharya SK, Sur D, Ali M, Kanungo S, You YA, Manna B, Sah B, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Dhingra MS, Donner A, Nair GB, Lopez AL, Wierzba TF, Clemens JD.

Lancet Infect Dis. 2013 Dec;13(12):1050-6. doi: 10.1016/S1473-3099(13)70273-1. Epub 2013 Oct 18. Erratum in: Lancet Infect Dis. 2013 Dec;13(12):1011.

PMID:
24140390
12.

Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.

Leung DT, Rahman MA, Mohasin M, Patel SM, Aktar A, Khanam F, Uddin T, Riyadh MA, Saha A, Alam MM, Chowdhury F, Khan AI, Charles R, LaRocque R, Harris JB, Calderwood SB, Qadri F, Ryan ET.

Clin Vaccine Immunol. 2012 May;19(5):690-8. doi: 10.1128/CVI.05615-11. Epub 2012 Mar 21. Erratum in: Clin Vaccine Immunol. 2012 Aug;19(8):1337.

13.

Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.

Tarique AA, Kalsy A, Arifuzzaman M, Rollins SM, Charles RC, Leung DT, Harris JB, Larocque RC, Sheikh A, Bhuiyan MS, Saksena R, Clements JD, Calderwood SB, Qadri F, Kovác P, Ryan ET.

Clin Vaccine Immunol. 2012 Apr;19(4):594-602. doi: 10.1128/CVI.05689-11. Epub 2012 Feb 22.

14.

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.

Trach DD, Clemens JD, Ke NT, Thuy HT, Son ND, Canh DG, Hang PV, Rao MR.

Lancet. 1997 Jan 25;349(9047):231-5.

PMID:
9014909
15.

Cholera vaccines for the developing world.

Lopez AL, Clemens JD, Deen J, Jodar L.

Hum Vaccin. 2008 Mar-Apr;4(2):165-9. Epub 2007 Oct 7. Review.

PMID:
18414029
16.

[Cholera vaccine].

Ehara M.

Nihon Rinsho. 2005 May;63 Suppl 5:625-30. Review. Japanese. No abstract available.

PMID:
15954420
17.

Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.

Kabir S.

Clin Vaccine Immunol. 2014 Sep;21(9):1195-205. doi: 10.1128/CVI.00378-14. Epub 2014 Jul 23. Review.

18.

Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.

Bishop AL, Schild S, Patimalla B, Klein B, Camilli A.

Infect Immun. 2010 Oct;78(10):4402-20. doi: 10.1128/IAI.00398-10. Epub 2010 Aug 2.

19.

Detection of Vibrio cholerae O1 and O139 in environmental waters of rural Bangladesh: a flow-cytometry-based field trial.

Righetto L, Zaman RU, Mahmud ZH, Bertuzzo E, Mari L, Casagrandi R, Gatto M, Islam S, Rinaldo A.

Epidemiol Infect. 2015 Aug;143(11):2330-42. doi: 10.1017/S0950268814003252. Epub 2014 Dec 11.

PMID:
25496520
20.

Use of a cholera rapid diagnostic test during a mass vaccination campaign in response to an epidemic in Guinea, 2012.

Martinez-Pino I, Luquero FJ, Sakoba K, Sylla S, Haile M, Grais RF, Ciglenecki I, Quilici ML, Page AL.

PLoS Negl Trop Dis. 2013 Aug 15;7(8):e2366. doi: 10.1371/journal.pntd.0002366. eCollection 2013.

Supplemental Content

Support Center